Summary

TNF rs1800629 (-308 G>A) determines your baseline TNF-alpha production — the A allele (TNF2) approximately doubles transcription of this master pro-inflammatory cytokine, affecting exercise recovery time, susceptibility to overtraining, baseline systemic inflammation, and autoimmune disease risk.

Genotype spectrum

GG (TNF1/TNF1)

Your inflammatory response is proportionate. Standard recovery timelines from training apply to you.

GA (TNF1/TNF2)

Your inflammatory system is slightly more responsive. This means faster initiation of the repair response to exercise-induced muscle damage.

AA (TNF2/TNF2)

Anti-inflammatory interventions produce the largest effect for you. Because your baseline TNF-alpha is constitutively elevated, anything that reduces chronic inflammation produces proportionally more benefit.

Practical takeaway

For GG Carriers (Standard TNF-alpha Production)
• Standard recovery protocols (48 hours between training same muscle groups, sleep 7-9 hours).
• General anti-inflammatory diet (Mediterranean-style, adequate omega-3 from fish or supplementation) for overall health.
• No specific TNF-targeted intervention needed.
For GA Carriers (Moderately Elevated)

Recovery:
• Allow 48-72 hours between intense sessions targeting the same muscle groups.
• Monitor for overtraining signs: persistent fatigue beyond 48 hours, declining performance across 2+ weeks, mood disturbance, elevated resting heart rate.
• Consider training periodisation with deliberate deload weeks (every 3-4 weeks, reduce volume by 40-50%).

Anti-inflammatory dietary support:
• Omega-3: 2-3g combined EPA/DHA daily (fish oil or algae-based).
• Polyphenol-rich foods daily: berries, dark chocolate (>70% cacao), green tea, turmeric.
• Tart cherry juice: 250-350ml twice daily around intense training periods. Evidence supports reduced DOMS and CRP (Tier 2).
• Minimise pro-inflammatory dietary patterns: excess omega-6 (seed oils), processed foods, high-glycemic meals.
For AA Carriers (High TNF-alpha Production)

Recovery (critical priority):
• 72+ hours between high-intensity sessions targeting the same muscle groups.
• Mandatory deload weeks every 3 weeks during intense training blocks.
• Sleep is your primary anti-inflammatory tool — prioritise 8-9 hours during heavy training periods.
• Track resting heart rate and HRV if possible — early warning systems for accumulated inflammatory load.
• Cold water immersion post-exercise (10-15°C, 10-15 min) may help attenuate the acute inflammatory peak. Evidence is mixed but mechanism is sound for high TNF-alpha producers.

Anti-inflammatory protocol (daily, not just around training):
• Omega-3: 3-4g combined EPA/DHA daily. This provides substrate for resolution mediators (resolvins, protectins).
• Curcumin: Standardised extract, 500-1000mg daily with fat for absorption. Directly inhibits NF-κB, the transcription factor that drives TNF-alpha production.
• Tart cherry juice: 250-350ml twice daily during training phases.
• Vitamin D: Ensure sufficiency (>75 nmol/L). Vitamin D

Evidence detail

What This Gene Does

TNF-alpha (tumor necrosis factor alpha) is one of the most potent pro-inflammatory cytokines in the human immune system. It's produced primarily by activated macrophages, T cells, and natural killer cells, and it orchestrates the acute inflammatory response — fever, vascular permeability, immune cell recruitment, and tissue remodelling. In controlled amounts, TNF-alpha is essential: it drives pathogen clearance, wound healing, and the adaptive response to exercise-induced muscle damage. But chronically elevated TNF-alpha is a driver of metabolic inflammation, insulin resistance, cardiovascular disease, and autoimmunity.

The rs1800629 variant (G>A) sits in the promoter region of the TNF gene, at position -308 relative to the transcription start site. The A allele (TNF2) creates a stronger transcription factor binding site, approximately doubling TNF-alpha mRNA transcription and protein production compared to the G allele (TNF1). This is a constitutive increase — carriers produce more TNF-alpha at baseline, and they produce proportionally more during any inflammatory stimulus (infection, exercise, tissue damage).

For exercise and recovery, this matters directly. Exercise-induced muscle damage triggers a local and systemic inflammatory response. TNF-alpha is one of the first cytokines released, initiating the repair cascade. Higher TNF-alpha production means a more aggressive inflammatory response to exercise damage — potentially faster initiation of repair but also greater muscle soreness, longer recovery windows, and higher susceptibility to overtraining syndrome with inadequate recovery.

Mechanism

TNF-alpha in exercise:

When you train hard enough to cause muscle fibre damage (eccentric exercise, heavy resistance training, unaccustomed exercise), the damaged fibres release damage-associated molecular patterns (DAMPs). These activate tissue-resident macrophages, which produce TNF-alpha as one of the first-response cytokines. TNF-alpha then:

1. Increases vascular permeability — allows immune cells to migrate from blood into damaged muscle tissue.
2. Recruits neutrophils and monocytes — amplifies the inflammatory response and debris clearance.
3. Activates satellite cells — TNF-alpha is actually required for muscle repair. It stimulates satellite cell proliferation, the process by which damaged muscle fibres are regenerated.
4. Induces muscle proteolysis — breaks down damaged proteins for recycling. This is the source of DOMS.
5. Generates systemic signals — the acute phase response, including CRP elevation, fever, fatigue, reduced appetite.

The dose-response problem:

TNF-alpha is essential for repair, but too much is destructive. The -308A allele shifts the dose-response curve — carriers produce more TNF-alpha per unit of muscle damage. This means:
• More intense DOMS — greater proteolytic activity during the repair phase.
• Longer recovery windows — the inflammatory phase persists longer before resolution.
• Higher overtraining risk — if training frequency exceeds the resolution rate, chronic low-grade inflammation accumulates (elevated resting CRP, persistent fatigue, declining performance, mood disturbance).

TNF-alpha and insulin resistance:

TNF-alpha activates IKKβ and JNK kinases inside cells, which phosphorylate insulin receptor substrate-1 (IRS-1) on serine residues instead of tyrosine residues. This serine phosphorylation blocks insulin signalling downstream — the cell becomes resistant to insulin even when insulin is present. In -308A carriers, chronically elevated TNF-alpha production creates a constant low-level insulin resistance signal, particularly in visceral adipose tissue. This is one mechanism by which chronic inflammation drives metabolic syndrome.

Resolution pathways (the intervention targets):

Inflammation resolution is an active process, not passive decay. Specialised pro-resolving mediators (SPMs) — resolvins, protectins, maresins — are produced from omega-3 fatty acids (EPA

TNF Alpha

Summary

Genotype spectrum

Practical takeaway

Evidence detail

Sources (10)